{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:07:52Z","timestamp":1790111272592,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX24_2051"],"award-info":[{"award-number":["SJCX24_2051"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903154"],"award-info":[{"award-number":["81903154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022\\u202FM711722"],"award-info":[{"award-number":["2022\\u202FM711722"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112895","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:16:10Z","timestamp":1789830970000},"page":"112895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lenalidomide triggers ferroptosis in multiple myeloma by blocking the c-Maf\/USP7 signaling pathway to induce the ubiquitination and degradation of FTH1"],"prefix":"10.1016","volume":"149","author":[{"given":"Erhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112895_bb0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1182\/blood.2024023841","article-title":"New prognostic systems for multiple myeloma in the context of contemporary therapies","volume":"146","author":"Spencer","year":"2025","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112895_bb0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41568-024-00755-x","article-title":"New horizons in our understanding of precursor multiple myeloma and early interception","volume":"24","author":"Cordas Dos Santos","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112895_bb0020","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1158\/1078-0432.CCR-16-0184","article-title":"New strategies in multiple myeloma: immunotherapy as a novel approach to treat patients with multiple myeloma","volume":"22","author":"Neri","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112895_bb0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41408-020-00350-x","article-title":"Immune-based therapies in the management of multiple myeloma","volume":"10","author":"Zanwar","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cellsig.2026.112895_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-med-050522-033815","article-title":"New biological therapies for multiple myeloma","volume":"75","author":"Garfall","year":"2024","journal-title":"Annu. Rev. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112895_bb0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.6004\/jnccn.2023.7100","article-title":"Integrating immune therapies for the treatment of multiple myeloma","volume":"21","author":"Mikkilineni","year":"2023","journal-title":"J. Natl. Compr. Canc. Ne."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41408-024-01139-y","article-title":"Bispecific antibodies in the treatment of multiple myeloma","volume":"14","author":"Devasia","year":"2024","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41408-024-01191-8","article-title":"CAR-T cell therapy in multiple myeloma: current status and future challenges","volume":"14","author":"Swan","year":"2024","journal-title":"Blood Cancer J."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112895_bb0055","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood.2023020284","article-title":"Potential future direction of measurable residual disease evaluation in multiple myeloma","volume":"142","author":"Mohty","year":"2023","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112895_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41577-024-01003-x","article-title":"Bone marrow inflammation in haematological malignancies","volume":"24","author":"de Jong","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112895_bb0065","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41375-025-02677-5","article-title":"The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed\/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Ntanasis-Stathopoulos","year":"2025","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01683-w","article-title":"Circulating biosignatures in multiple myeloma and their role in multidrug resistance","volume":"22","author":"Krishnan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112895_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","article-title":"Recommendations for robust and reproducible research on ferroptosis","volume":"26","author":"Mishima","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112895_bb0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112895_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112895_bb0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112895_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-024-01999-9","article-title":"Ferroptotic therapy in cancer: benefits, side effects, and risks","volume":"23","author":"Diao","year":"2024","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112895_bb0105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s11864-024-01250-z","article-title":"Research Progress on Ferroptosis in multiple myeloma","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3\u20134","key":"10.1016\/j.cellsig.2026.112895_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10495-023-01909-2","article-title":"Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10238-025-01673-4","article-title":"DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis","volume":"25","author":"Wang","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112895_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","article-title":"Mechanisms controlling cellular and systemic iron homeostasis","volume":"25","author":"Galy","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112895_bb0125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting Ferroptosis to Iron out Cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40364-023-00457-w","article-title":"The role and regulation of Maf proteins in cancer","volume":"11","author":"Deng","year":"2023","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02551-4","article-title":"MAFB: a key regulator of myeloid commitment involved in hematological diseases","volume":"11","author":"Ventura","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112895_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215791","article-title":"Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma","volume":"543","author":"Jiang","year":"2022","journal-title":"Cancer Lett."},{"issue":"25","key":"10.1016\/j.cellsig.2026.112895_bb0145","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1182\/blood-2016-03-706077","article-title":"MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma","volume":"128","author":"Qiang","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.67","article-title":"GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target","volume":"4","author":"Herath","year":"2014","journal-title":"Blood Cancer J."},{"issue":"6168","key":"10.1016\/j.cellsig.2026.112895_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112895_bb0160","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.941742","article-title":"Lenalidomide induces degradation of IKZF1 and IKZF3","volume":"3","author":"Kr\u00f6nke","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellsig.2026.112895_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies","volume":"2","author":"Kotla","year":"2009","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112895_bb0170","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0000000000003093","article-title":"Lenalidomide long-term neurotoxicity: clinical and neurophysiologic prospective study","volume":"87","author":"Dalla Torre","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112895_bb0175","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/bjh.14801","article-title":"MUC1-C is a target in lenalidomide resistant multiple myeloma","volume":"178","author":"Yin","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"10272","key":"10.1016\/j.cellsig.2026.112895_bb0180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"issue":"46","key":"10.1016\/j.cellsig.2026.112895_bb0185","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1038\/sj.onc.1208844","article-title":"ARK5 is transcriptionally regulated by the large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma","volume":"24","author":"Suzuki","year":"2005","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112895_bb0190","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1074\/jbc.RA119.010724","article-title":"The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival","volume":"295","author":"He","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112895_bb0195","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41401-019-0249-1","article-title":"Mebendazole elicits potent antimyeloma activity by inhibiting the USP5\/c-Maf axis","volume":"40","author":"Chen","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112895_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112895_bb0205","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112895_bb0210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12915-025-02378-6","article-title":"Iron metabolism and ferroptosis in human health and disease","volume":"23","author":"Zhong","year":"2025","journal-title":"BMC Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112895_bb0220","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41556-024-01361-7","article-title":"Ironing out the details of ferroptosis","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112895_bb0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112895_bb0230","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0235","article-title":"Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: a therapeutic strategy for triple-negative breast cancer","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cellsig.2026.112895_bb0240","first-page":"23","article-title":"Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112895_bb0245","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41467-024-48151-1","article-title":"Structural basis for the intracellular regulation of ferritin degradation","volume":"15","author":"Hoelzgen","year":"2024","journal-title":"Nat. Commun."},{"issue":"7498","key":"10.1016\/j.cellsig.2026.112895_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112895_bb0255","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.7150\/ijbs.80324","article-title":"Polyphyllin B suppresses gastric tumor growth by modulating Iron metabolism and inducing Ferroptosis","volume":"19","author":"Hu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112895_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115188","article-title":"Sodium butyrate induces ferroptosis in colorectal cancer cells by promoting NCOA4-FTH1-mediated ferritinophagy","volume":"163","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112895_bb0265","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202403160R","article-title":"Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy","volume":"39","author":"Huang","year":"2025","journal-title":"FASEB J."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2026.112895_bb0270","article-title":"Heme oxygenase-1 (HO-1) depletion promotes ferroptosis to reverse cisplatin-resistance via enhancing NCOA4-mediated ferritinophagy in ovarian cancer","volume":"327","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:32:40Z","timestamp":1790109160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":54,"alternative-id":["S0898656826005541"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112895","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenalidomide triggers ferroptosis in multiple myeloma by blocking the c-Maf\/USP7 signaling pathway to induce the ubiquitination and degradation of FTH1","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112895"}}